Evidence map›Paper›PMID 32926257›Full record

ArticleCellular and molecular neurobiology2022

Morphine and Fentanyl Repeated Administration Induces Different Levels of NLRP3-Dependent Pyroptosis in the Dorsal Raphe Nucleus of Male Rats via Cell-Specific Activation of TLR4 and Opioid Receptors.

César J Carranza-Aguilar, Araceli Hernández-Mendoza, Carlos Mejias-Aponte, Kenner C Rice, Marisela Morales, Claudia González-Espinosa, Silvia L Cruz

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular neurobiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 64 citations in OpenAlex.

  1. Trial
  2. The neuroimmune-glutamate hypothesis of addiction.Neuroscience and biobehavioral reviews · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Epigenetic mechanisms of HIV and opioid-induced neuropathology: Potential therapies and interventions.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

César J Carranza-AguilarDepartamento de Farmacobiología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav, IPN), Sede Sur, Calzada de los Tenorios No. 235, Col. Granjas Coapa, Del. Tlalpan, C.P. 14330, Ciudad de México, Mexico.ORCID https://orcid.org/0000-0001-9117-1611
Araceli Hernández-MendozaDepartamento de Farmacobiología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav, IPN), Sede Sur, Calzada de los Tenorios No. 235, Col. Granjas Coapa, Del. Tlalpan, C.P. 14330, Ciudad de México, Mexico.ORCID https://orcid.org/0000-0002-4704-513X
Carlos Mejias-AponteNeuronal Networks Section, Integrative Neuroscience Research Branch, National Institute on Drug Abuse, 251 Bayview Boulevard Suite 200, Baltimore, MD, 21224, USA.ORCID https://orcid.org/0000-0002-6909-1831
Kenner C RiceDrug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.ORCID https://orcid.org/0000-0002-1147-9147
Marisela MoralesNeuronal Networks Section, Integrative Neuroscience Research Branch, National Institute on Drug Abuse, 251 Bayview Boulevard Suite 200, Baltimore, MD, 21224, USA.ORCID https://orcid.org/0000-0002-3845-9402
Claudia González-Espinosa *Departamento de Farmacobiología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav, IPN), Sede Sur, Calzada de los Tenorios No. 235, Col. Granjas Coapa, Del. Tlalpan, C.P. 14330, Ciudad de México, Mexico.ORCID https://orcid.org/0000-0001-7332-3829
Silvia L Cruz *Departamento de Farmacobiología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav, IPN), Sede Sur, Calzada de los Tenorios No. 235, Col. Granjas Coapa, Del. Tlalpan, C.P. 14330, Ciudad de México, Mexico. slcruzm@cinvestav.mx.ORCID http://orcid.org/0000-0002-8617-3556
Instituto Politécnico Nacional · MXNational Institute on Drug Abuse · US

Funding

Neuronal connectivity within the mesolimbic systemZIADA000511 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI MORALES, MARISELA · 2009 to 2025
$35.0M
Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid ReceptorsZIADA000527 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI RICE, KENNER · 2009 to 2025
$23.2M
Consejo Nacional de Ciencia y Tecnología 338376SEP-Cinvestav 101
6 · The paper itself

Abstract

Morphine promotes neuroinflammation after NOD-like receptor protein 3 (NLRP3) oligomerization in glial cells, but the capacity of other opioids to induce neuroinflammation and its relationship to the development of analgesic tolerance is unknown. We studied the effects of morphine and fentanyl on NLRP3 inflammasome activation in glial and neuronal cells in the dorsal raphe nucleus (DRN), a region involved in pain regulation. Male Wistar rats received i.p. injections of morphine (10 mg/kg) or fentanyl (0.1 mg/kg) 3 × daily for 7 days and were tested for nociception. Two hours after the last (19th) administration, we analyzed NLRP3 oligomerization, caspase-1 activation and gasdermin D-N (GSDMD-N) expression in microglia (CD11b positive cells), astrocytes (GFAP-positive cells) and neurons (NeuN-positive cells). Tolerance developed to both opioids, but only fentanyl produced hyperalgesia. Morphine and fentanyl activated NLRP3 inflammasome in astrocytes and serotonergic (TPH-2-positive) neurons, but fentanyl effects were more pronounced. Both opioids increased GFAP and CD11b immunoreactivity, caspase-1 and GSDMD activation, indicating pyroptotic cell death. The opioid receptor antagonist (-)-naloxone, but not the TLR4 receptor antagonist (+)-naloxone, prevented microglia activation and NLRP3 oligomerization. Only (+)-naloxone prevented astrocytes' activation. The anti-inflammatory agent minocycline and the NLRP3 inhibitor MCC950 delayed tolerance to morphine and fentanyl antinociception and prevented fentanyl-induced hyperalgesia. MCC950 also prevented opioid-induced NLRP3 oligomerization. In conclusion, morphine and fentanyl differentially induce cell-specific activation of NLRP3 inflammasome and pyroptosis in the DRN through TLR4 receptors in astrocytes and through opioid receptors in neurons, indicating that neuroinflammation is involved in opioid-induced analgesia and fentanyl-induced hyperalgesia after repeated administrations.

Indexed as

FentanylMorphineAnalgesics, OpioidAnimalsDorsal Raphe NucleusMaleNLR Family, Pyrin Domain-Containing 3 ProteinNLR ProteinsPyroptosisRatsRats, WistarReceptors, OpioidToll-Like Receptor 4Analgesics, OpioidFentanylMorphineNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, ratNLR ProteinsReceptors, OpioidTlr4 protein, ratToll-Like Receptor 4GliaNF-κBNLRP3OpioidsSerotoninTLR4

Identifiers

PMID32926257
PMCPMC11441185
OpenAlexW3085008801

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.